Key Points FLT3-TKD/NPM1 double mutation status is associated with superior relapse-free survival compared with NPM1-only–mutated AML. Allogeneic stem cell transplant in complete responders does not improve outcomes in FLT3-TKD/NPM1 AML patients.
No takes yet. Share an insight, caveat, or question.
Boddu et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: